Stagezero Life Sciences Ltd (SZLSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,947 | -5,911 | -6,017 | -6,951 | -9,130 |
| Depreciation Amortization | 347 | 342 | 4 | 17 | 0 |
| Accounts receivable | 31 | -64 | 494 | N/A | N/A |
| Accounts payable and accrued liabilities | 259 | -347 | 214 | 176 | N/A |
| Other Working Capital | 595 | -386 | 777 | -357 | 210 |
| Other Operating Activity | -2,108 | 2,569 | 2,801 | 5,519 | 4,440 |
| Operating Cash Flow | $-3,823 | $-3,796 | $-1,726 | $-1,595 | $-4,480 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -1 | -3 | -10 |
| Net Acquisitions | N/A | -34 | -2,570 | -4,923 | 0 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 240 |
| Investing Cash Flow | $N/A | $-34 | $-2,571 | $-4,926 | $230 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 583 | 1,150 | N/A | N/A | N/A |
| Debt Issued | 1,600 | 537 | N/A | N/A | N/A |
| Debt Repayment | -160 | -50 | N/A | -258 | N/A |
| Common Stock Issued | 1,812 | 2,114 | 2,100 | 6,814 | N/A |
| Other Financing Activity | -184 | -222 | 356 | -55 | -470 |
| Financing Cash Flow | $3,651 | $3,529 | $2,456 | $6,501 | $-470 |
| Exchange Rate Effect | N/A | N/A | 18 | -419 | 60 |
| Beginning Cash Position | 214 | 516 | 2,339 | 2,778 | 7,530 |
| End Cash Position | 41 | 214 | 516 | 2,339 | 2,860 |
| Net Cash Flow | $-173 | $-302 | $-1,823 | $-439 | $-4,660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,823 | -3,796 | -1,726 | -1,595 | -4,480 |
| Capital Expenditure | N/A | N/A | -1 | -3 | N/A |
| Free Cash Flow | -3,823 | -3,796 | -1,727 | -1,599 | -4,480 |